Unlocking chemical matter on scale

webinar

Tue, 07 Jul 2020, 17:00 CEST (Berlin)

Dr. Serghei Glinca, CEO Crystals First GmbH, Marburg, Germany

Unlocking chemical matter on scale

Fragment-based lead discovery (FBLD) has undoubtedly become an invaluable resource for medicinal chemists in the identification of lead candidates.

Since an efficient fragment evolution requires structural data of protein-ligand interactions, a variety of biophysical methods are applied in a cascade approach as a set of prefilter prior to structure determination. Systematic studies suggest that the cascade approach significantly reduces the hit rate compared to a direct crystallographic screening.

The application of X-ray crystallography as a primary fragment screening method has been underutilized due to the limited availability of a robust system for soaking experiments and solubility issues of fragments. One of major bottlenecks in the experimental setup for crystal soaking is the sensitivity of protein crystals. We overcome this limitation using the SmartSoak® technology, which stabilizes protein crystals leading to high-performance soaking systems. No trial-and-error optimization of the soaking system needed.

In case studies, we demonstrate the advantages of the application of crystallographic fragment screening as a primary screening strategy for the hit identification. The resulting structural data can now be utilized to explore the chemical space on scale using computational methods.

Current news

category
Challenge
BioSolveIT Crowns Two Winners of the Scientific Challenge Winter 2023
December 19, 2024 08:43 CET
We are proud to announce not one, but two winners of the Scientific Challenge Winter 2024: Harry Tran and Katharina Buchthal! Due to the exceptional achievements and execution within both projects, it was simply too difficult for us to choose just one outstanding entry. As a result, we decided to...
Read on
category
Software
Peptide Design with New FastGrow Sets
December 17, 2024 10:00 CET
FastGrow now enables efficient and lightning-fast structure-based peptide design with two new libraries. These are the largest sets to date, containing over 661,000 combinations of proteinogenic amino acids and amide bioisosteres, which can be screened within seconds for the best shape-complementary solutions. How are the sets designed? Both sets are...
Read on
category
Software
HPSee 2.0: Unlocking Speed and Scale in Drug Discovery
November 8, 2024 14:00 CET
Imagine you’re part of a team looking for new potential compunds and screening ultra-vast Chemical Spaces to find the right ones. But running these massive calculations requires serious computing power, and managing all that data can be complicated and time-consuming. That’s where HPSee steps in, making the whole process simpler,...
Read on